Does the media refer more to TMCI or AVR?

In the previous week, Treace Medical Concepts had 1 more articles in the media than Anteris Technologies Global. MarketBeat recorded 5 mentions for Treace Medical Concepts and 4 mentions for Anteris Technologies Global. Treace Medical Concepts' average media sentiment score of 1.56 beat Anteris Technologies Global's score of 0.36 indicating that Treace Medical Concepts is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Treace Medical Concepts 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Anteris Technologies Global 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to TMCI or DRTS?

In the previous week, Alpha Tau Medical had 1 more articles in the media than Treace Medical Concepts. MarketBeat recorded 6 mentions for Alpha Tau Medical and 5 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 1.56 beat Alpha Tau Medical's score of 0.31 indicating that Treace Medical Concepts is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Treace Medical Concepts 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Alpha Tau Medical 0 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to TMCI or BVS?

In the previous week, Treace Medical Concepts had 1 more articles in the media than Bioventus. MarketBeat recorded 5 mentions for Treace Medical Concepts and 4 mentions for Bioventus. Treace Medical Concepts' average media sentiment score of 1.56 beat Bioventus' score of 1.00 indicating that Treace Medical Concepts is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Treace Medical Concepts 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Bioventus 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to TMCI or SSII?

In the previous week, Treace Medical Concepts had 3 more articles in the media than SS Innovations International. MarketBeat recorded 5 mentions for Treace Medical Concepts and 2 mentions for SS Innovations International. Treace Medical Concepts' average media sentiment score of 1.56 beat SS Innovations International's score of 1.16 indicating that Treace Medical Concepts is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Treace Medical Concepts 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive SS Innovations International 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Treace Medical Concepts (TMCI) Competitors

$3.94 -0.12 (-2.83%)

As of 10:20 AM Eastern

Compare

TMCI vs. AVR, INMD, DRTS, BVS, and SSII

Should you buy Treace Medical Concepts stock or one of its competitors? MarketBeat compares Treace Medical Concepts with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Treace Medical Concepts include Anteris Technologies Global (AVR), InMode (INMD), Alpha Tau Medical (DRTS), Bioventus (BVS), and SS Innovations International (SSII). These companies are all part of the "medical equipment" industry.

How does Treace Medical Concepts compare to Anteris Technologies Global?

Treace Medical Concepts (NASDAQ:TMCI) and Anteris Technologies Global (NASDAQ:AVR) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, dividends, analyst recommendations, earnings, risk, profitability and valuation.

84.1% of Treace Medical Concepts shares are owned by institutional investors. 23.4% of Treace Medical Concepts shares are owned by company insiders. Comparatively, 4.5% of Anteris Technologies Global shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Treace Medical Concepts has a net margin of -29.44% compared to Anteris Technologies Global's net margin of -5,148.78%. Treace Medical Concepts' return on equity of -67.04% beat Anteris Technologies Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Treace Medical Concepts	-29.44%	-67.04%	-30.28%
Anteris Technologies Global	-5,148.78%	-124.76%	-101.21%

Treace Medical Concepts presently has a consensus price target of $4.77, indicating a potential upside of 20.91%. Anteris Technologies Global has a consensus price target of $16.00, indicating a potential upside of 72.51%. Given Anteris Technologies Global's stronger consensus rating and higher probable upside, analysts clearly believe Anteris Technologies Global is more favorable than Treace Medical Concepts.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86
Anteris Technologies Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

In the previous week, Treace Medical Concepts had 1 more articles in the media than Anteris Technologies Global. MarketBeat recorded 5 mentions for Treace Medical Concepts and 4 mentions for Anteris Technologies Global. Treace Medical Concepts' average media sentiment score of 1.56 beat Anteris Technologies Global's score of 0.36 indicating that Treace Medical Concepts is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Treace Medical Concepts	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Anteris Technologies Global	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Treace Medical Concepts has a beta of 1.39, indicating that its share price is 39% more volatile than the broader market. Comparatively, Anteris Technologies Global has a beta of 1.77, indicating that its share price is 77% more volatile than the broader market.

Treace Medical Concepts has higher revenue and earnings than Anteris Technologies Global. Anteris Technologies Global is trading at a lower price-to-earnings ratio than Treace Medical Concepts, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Treace Medical Concepts	$212.69M	1.20	-$59M	-$0.97	N/A
Anteris Technologies Global	$1.91M	472.69	-$94.14M	-$2.23	N/A

Summary

Treace Medical Concepts beats Anteris Technologies Global on 11 of the 16 factors compared between the two stocks.

How does Treace Medical Concepts compare to InMode?

InMode (NASDAQ:INMD) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment and valuation.

InMode has a beta of 1.94, indicating that its stock price is 94% more volatile than the broader market. Comparatively, Treace Medical Concepts has a beta of 1.39, indicating that its stock price is 39% more volatile than the broader market.

InMode presently has a consensus target price of $16.00, indicating a potential upside of 18.52%. Treace Medical Concepts has a consensus target price of $4.77, indicating a potential upside of 20.91%. Given Treace Medical Concepts' higher possible upside, analysts clearly believe Treace Medical Concepts is more favorable than InMode.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InMode	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86

InMode has a net margin of 23.27% compared to Treace Medical Concepts' net margin of -29.44%. InMode's return on equity of 13.47% beat Treace Medical Concepts' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InMode	23.27%	13.47%	11.95%
Treace Medical Concepts	-29.44%	-67.04%	-30.28%

68.0% of InMode shares are held by institutional investors. Comparatively, 84.1% of Treace Medical Concepts shares are held by institutional investors. 6.9% of InMode shares are held by insiders. Comparatively, 23.4% of Treace Medical Concepts shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Treace Medical Concepts had 4 more articles in the media than InMode. MarketBeat recorded 5 mentions for Treace Medical Concepts and 1 mentions for InMode. InMode's average media sentiment score of 1.89 beat Treace Medical Concepts' score of 1.56 indicating that InMode is being referred to more favorably in the media.

Company	Overall Sentiment
InMode	Very Positive
Treace Medical Concepts	Very Positive

InMode has higher revenue and earnings than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InMode	$374.64M	2.28	$93.83M	$1.36	9.93
Treace Medical Concepts	$212.69M	1.20	-$59M	-$0.97	N/A

Summary

InMode beats Treace Medical Concepts on 11 of the 15 factors compared between the two stocks.

How does Treace Medical Concepts compare to Alpha Tau Medical?

Treace Medical Concepts (NASDAQ:TMCI) and Alpha Tau Medical (NASDAQ:DRTS) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, analyst recommendations, earnings, dividends and profitability.

Treace Medical Concepts has a beta of 1.39, indicating that its stock price is 39% more volatile than the broader market. Comparatively, Alpha Tau Medical has a beta of 1.19, indicating that its stock price is 19% more volatile than the broader market.

84.1% of Treace Medical Concepts shares are owned by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are owned by institutional investors. 23.4% of Treace Medical Concepts shares are owned by company insiders. Comparatively, 39.5% of Alpha Tau Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Alpha Tau Medical has a net margin of 0.00% compared to Treace Medical Concepts' net margin of -29.44%. Treace Medical Concepts' return on equity of -67.04% beat Alpha Tau Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Treace Medical Concepts	-29.44%	-67.04%	-30.28%
Alpha Tau Medical	N/A	-73.23%	-52.90%

Alpha Tau Medical has lower revenue, but higher earnings than Treace Medical Concepts. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Treace Medical Concepts, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Treace Medical Concepts	$212.69M	1.20	-$59M	-$0.97	N/A
Alpha Tau Medical	N/A	N/A	-$42.63M	-$0.67	N/A

Treace Medical Concepts presently has a consensus price target of $4.77, indicating a potential upside of 20.91%. Alpha Tau Medical has a consensus price target of $12.60, indicating a potential upside of 29.70%. Given Alpha Tau Medical's stronger consensus rating and higher probable upside, analysts plainly believe Alpha Tau Medical is more favorable than Treace Medical Concepts.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86
Alpha Tau Medical	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43

In the previous week, Alpha Tau Medical had 1 more articles in the media than Treace Medical Concepts. MarketBeat recorded 6 mentions for Alpha Tau Medical and 5 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 1.56 beat Alpha Tau Medical's score of 0.31 indicating that Treace Medical Concepts is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Treace Medical Concepts	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Alpha Tau Medical	0 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Alpha Tau Medical beats Treace Medical Concepts on 8 of the 15 factors compared between the two stocks.

How does Treace Medical Concepts compare to Bioventus?

Treace Medical Concepts (NASDAQ:TMCI) and Bioventus (NASDAQ:BVS) are both small-cap medical equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, analyst recommendations, profitability, earnings, valuation and media sentiment.

In the previous week, Treace Medical Concepts had 1 more articles in the media than Bioventus. MarketBeat recorded 5 mentions for Treace Medical Concepts and 4 mentions for Bioventus. Treace Medical Concepts' average media sentiment score of 1.56 beat Bioventus' score of 1.00 indicating that Treace Medical Concepts is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Treace Medical Concepts	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Bioventus	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Treace Medical Concepts has a beta of 1.39, indicating that its stock price is 39% more volatile than the broader market. Comparatively, Bioventus has a beta of 0.67, indicating that its stock price is 33% less volatile than the broader market.

Bioventus has higher revenue and earnings than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Bioventus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Treace Medical Concepts	$212.69M	1.20	-$59M	-$0.97	N/A
Bioventus	$568.09M	1.25	$22.73M	$0.41	20.77

84.1% of Treace Medical Concepts shares are owned by institutional investors. Comparatively, 62.9% of Bioventus shares are owned by institutional investors. 23.4% of Treace Medical Concepts shares are owned by insiders. Comparatively, 33.0% of Bioventus shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Treace Medical Concepts currently has a consensus target price of $4.77, indicating a potential upside of 20.91%. Bioventus has a consensus target price of $14.00, indicating a potential upside of 64.38%. Given Bioventus' stronger consensus rating and higher probable upside, analysts clearly believe Bioventus is more favorable than Treace Medical Concepts.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86
Bioventus	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.00

Bioventus has a net margin of 4.94% compared to Treace Medical Concepts' net margin of -29.44%. Bioventus' return on equity of 29.97% beat Treace Medical Concepts' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Treace Medical Concepts	-29.44%	-67.04%	-30.28%
Bioventus	4.94%	29.97%	9.52%

Summary

Bioventus beats Treace Medical Concepts on 13 of the 17 factors compared between the two stocks.

How does Treace Medical Concepts compare to SS Innovations International?

Treace Medical Concepts (NASDAQ:TMCI) and SS Innovations International (NASDAQ:SSII) are both small-cap medical equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, dividends, analyst recommendations, institutional ownership, valuation and profitability.

SS Innovations International has lower revenue, but higher earnings than Treace Medical Concepts. SS Innovations International is trading at a lower price-to-earnings ratio than Treace Medical Concepts, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Treace Medical Concepts	$212.69M	1.20	-$59M	-$0.97	N/A
SS Innovations International	$42.49M	16.20	-$12.13M	-$0.05	N/A

Treace Medical Concepts presently has a consensus price target of $4.77, indicating a potential upside of 20.91%. SS Innovations International has a consensus price target of $7.00, indicating a potential upside of 103.55%. Given SS Innovations International's higher possible upside, analysts clearly believe SS Innovations International is more favorable than Treace Medical Concepts.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86
SS Innovations International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

84.1% of Treace Medical Concepts shares are held by institutional investors. 23.4% of Treace Medical Concepts shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

SS Innovations International has a net margin of -20.69% compared to Treace Medical Concepts' net margin of -29.44%. SS Innovations International's return on equity of -23.00% beat Treace Medical Concepts' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Treace Medical Concepts	-29.44%	-67.04%	-30.28%
SS Innovations International	-20.69%	-23.00%	-13.18%

In the previous week, Treace Medical Concepts had 3 more articles in the media than SS Innovations International. MarketBeat recorded 5 mentions for Treace Medical Concepts and 2 mentions for SS Innovations International. Treace Medical Concepts' average media sentiment score of 1.56 beat SS Innovations International's score of 1.16 indicating that Treace Medical Concepts is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Treace Medical Concepts	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
SS Innovations International	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Treace Medical Concepts has a beta of 1.39, suggesting that its share price is 39% more volatile than the broader market. Comparatively, SS Innovations International has a beta of -1.89, suggesting that its share price is 289% less volatile than the broader market.

Summary

Treace Medical Concepts beats SS Innovations International on 9 of the 16 factors compared between the two stocks.

Get Treace Medical Concepts News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TMCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TMCI vs. The Competition

Export

Metric	Treace Medical Concepts	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$252.09M	$7.10B	$6.49B	$12.31B
Dividend Yield	N/A	1.21%	2.67%	5.66%
P/E Ratio	-4.01	48.66	24.05	24.76
Price / Sales	1.20	83.85	542.61	168.32
Price / Cash	N/A	25.59	27.48	37.92
Price / Book	2.88	6.95	10.69	6.90
Net Income	-$59M	$159.20M	$3.57B	$337.45M
7 Day Performance	11.76%	0.12%	1.56%	2.84%
1 Month Performance	48.31%	6.17%	2.49%	4.78%
1 Year Performance	-30.42%	3.22%	26.51%	33.08%

Treace Medical Concepts Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TMCI Treace Medical Concepts	3.0842 of 5 stars	$3.95 -2.8%	$4.77 +20.9%	-28.4%	$252.09M	$212.69M	N/A	250	Positive News
AVR Anteris Technologies Global	3.6918 of 5 stars	$9.47 +1.4%	$16.00 +69.0%	+108.9%	$909.18M	$1.91M	N/A	138
INMD InMode	3.5689 of 5 stars	$13.56 +0.4%	$16.00 +18.0%	+0.7%	$855.34M	$370.49M	9.97	480
DRTS Alpha Tau Medical	3.6054 of 5 stars	$9.19 -1.0%	$12.60 +37.1%	+225.1%	$838.22M	N/A	N/A	80
BVS Bioventus	4.4725 of 5 stars	$9.20 +2.8%	$14.00 +52.2%	N/A	$747.64M	$568.09M	22.44	1,200	Positive News Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TMCI) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Treace Medical Concepts (TMCI) Competitors

TMCI vs. AVR, INMD, DRTS, BVS, and SSII

How does Treace Medical Concepts compare to Anteris Technologies Global?

Summary

How does Treace Medical Concepts compare to InMode?

Summary

How does Treace Medical Concepts compare to Alpha Tau Medical?

Summary

How does Treace Medical Concepts compare to Bioventus?

Summary

How does Treace Medical Concepts compare to SS Innovations International?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMCI vs. The Competition

Treace Medical Concepts Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Treace Medical Concepts (TMCI) Competitors

TMCI vs. AVR, INMD, DRTS, BVS, and SSII

How does Treace Medical Concepts compare to Anteris Technologies Global?

Do insiders & institutionals have more ownership in TMCI or AVR?

Is TMCI or AVR more profitable?

Do analysts prefer TMCI or AVR?

Does the media refer more to TMCI or AVR?

Which has more volatility and risk, TMCI or AVR?

Which has preferable valuation & earnings, TMCI or AVR?

Summary

How does Treace Medical Concepts compare to InMode?

Which has more risk and volatility, INMD or TMCI?

Do analysts rate INMD or TMCI?

Is INMD or TMCI more profitable?

Do insiders and institutionals believe in INMD or TMCI?

Does the media favor INMD or TMCI?

Which has preferable valuation and earnings, INMD or TMCI?

Summary

How does Treace Medical Concepts compare to Alpha Tau Medical?

Which has more volatility & risk, TMCI or DRTS?

Do institutionals & insiders have more ownership in TMCI or DRTS?

Is TMCI or DRTS more profitable?

Which has better valuation and earnings, TMCI or DRTS?

Do analysts prefer TMCI or DRTS?

Does the media refer more to TMCI or DRTS?

Summary

How does Treace Medical Concepts compare to Bioventus?

Does the media refer more to TMCI or BVS?

Which has more volatility and risk, TMCI or BVS?

Which has preferable earnings & valuation, TMCI or BVS?

Do institutionals and insiders have more ownership in TMCI or BVS?

Do analysts prefer TMCI or BVS?

Is TMCI or BVS more profitable?

Summary

How does Treace Medical Concepts compare to SS Innovations International?

Which has preferable valuation and earnings, TMCI or SSII?

Do analysts recommend TMCI or SSII?

Do institutionals & insiders believe in TMCI or SSII?

Is TMCI or SSII more profitable?

Does the media refer more to TMCI or SSII?

Which has more risk and volatility, TMCI or SSII?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMCI vs. The Competition

Treace Medical Concepts Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools